1. 2) Ellman MH, Hurwitz H, Thomas C, et al. : Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18: 1741–1743, 1991.
2. 3) Salloum E, Cooper DL, Howe G, et al. : Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14: 1943–1949, 1996.
3. 4) Georgescu L, Quinn GC, Schwartzman S, et al. : Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Semin Arthritis Rheum 26: 794–804, 1997.
4. 5) Harris NL and Swerdlow SH : Methotrexate-associated lymphoproliferative disorders. World Health Organization Classification of Tumours: Pathology and genetics of tumours of haematopoietic and lymphoid tissues (ed by Jaffe ES, Harris NL, Stein H, et al.). pp 270–271, IARC Press, Lyon, 2001.
5. 6) Gaulard P, Swerdlow SH, Harris NL, et al. : Other iatrogenic immunodeficiency-associated lymphoproliferated disorders. WHO Classification of tumours of haematopoietic and lymphoid tissues (ed by Swerdlow SH, Campo E, Harris NL, et al.). pp 350–351, IARC Press, Lyon, 2008.